EVERNORTH ENGUIDE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

EVERNORTH ENGUIDE Trademark

Serial Number: 99021043

EVERNORTH ENGUIDE is a trademark filed by Express Scripts Strategic Development, Inc. on January 28, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Express Scripts Strategic Development, Inc. (5 trademarks)

One Express Way
St. Louis, MO 63121

Entity Type: 03

Trademark Details

Filing Date

January 28, 2025

Registration Date

Not Registered

Published for Opposition

January 13, 2026

Goods & Services

Downloadable computer application software for providing information regarding prescription medications; Downloadable computer application software for pharmacy patients to receive information and updates regarding pharmacy orders, and renewals and alerts regarding prescription medications; Downloadable reports of the effectiveness of tailored health messaging and support at the patient level

Conducting and arranging business conferences in the field of pharmacy benefit management

Mail order and Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; drug utilization review services; pharmaceutical cost management services; Strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; market analysis and preparation of market analysis reports of the effectiveness of tailored health messaging and support at the patient level; providing information in the field of pharmaceutical cost management as provided to pharmacy benefit management services clients, consultants and brokers; Retail pharmacy services featuring home delivery of prescription medications; Mail order pharmacy services

Advisory services and consultancy regarding healthcare; Healthcare services, namely, wellness and disease management programs; Medicare prescription coverage plan services, namely, disease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance, and providing information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcare, pharmaceuticals; providing information in the field of healthcare as provided to pharmacy benefit management services clients, consultants and brokers

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 10, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 13, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 7, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 5, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 5, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 5, 2025 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 28, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 25, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 9, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 30, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 28, 2025 MAFR
NEW APPLICATION ENTERED
Jan 28, 2025 NWAP